Annabel Tuckfield

522 total citations
15 papers, 393 citations indexed

About

Annabel Tuckfield is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Annabel Tuckfield has authored 15 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 6 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Annabel Tuckfield's work include Hemoglobinopathies and Related Disorders (3 papers), Acute Myeloid Leukemia Research (2 papers) and Renal Transplantation Outcomes and Treatments (2 papers). Annabel Tuckfield is often cited by papers focused on Hemoglobinopathies and Related Disorders (3 papers), Acute Myeloid Leukemia Research (2 papers) and Renal Transplantation Outcomes and Treatments (2 papers). Annabel Tuckfield collaborates with scholars based in Australia, United States and Japan. Annabel Tuckfield's co-authors include Michael Haeusler, Andrew Grigg, John M. Cunningham, Stephen M. Jane, Tomasz Wilanowski, J. Metz, Loretta Cerruti, Jianning Tao, Sinead O’Connell and Robert Saint and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Molecular and Cellular Biology.

In The Last Decade

Annabel Tuckfield

15 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annabel Tuckfield Australia 10 172 104 77 66 47 15 393
Athinoula Meli United Kingdom 8 88 0.5× 144 1.4× 34 0.4× 41 0.6× 7 0.1× 15 346
Michael Janisiw Austria 11 250 1.5× 118 1.1× 13 0.2× 20 0.3× 16 0.3× 17 448
Mariagabriella Mariani Italy 9 53 0.3× 183 1.8× 13 0.2× 155 2.3× 7 0.1× 11 373
C Sartiaux France 7 173 1.0× 112 1.1× 19 0.2× 68 1.0× 3 0.1× 8 505
LM Snyder United States 12 145 0.8× 139 1.3× 15 0.2× 179 2.7× 5 0.1× 17 523
Francesca La Carpia United States 8 124 0.7× 62 0.6× 10 0.1× 48 0.7× 1 0.0× 15 281
Nisha Vasavda United Kingdom 13 130 0.8× 290 2.8× 3 0.0× 319 4.8× 6 0.1× 19 575
Cherylene A. Plewa United States 6 121 0.7× 278 2.7× 9 0.1× 219 3.3× 1 0.0× 8 444
B J Warn-Cramer United States 12 149 0.9× 422 4.1× 3 0.0× 124 1.9× 15 608
Massimo Amelotti Italy 5 100 0.6× 12 0.1× 14 0.2× 5 0.1× 3 0.1× 7 229

Countries citing papers authored by Annabel Tuckfield

Since Specialization
Citations

This map shows the geographic impact of Annabel Tuckfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annabel Tuckfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annabel Tuckfield more than expected).

Fields of papers citing papers by Annabel Tuckfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annabel Tuckfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annabel Tuckfield. The network helps show where Annabel Tuckfield may publish in the future.

Co-authorship network of co-authors of Annabel Tuckfield

This figure shows the co-authorship network connecting the top 25 collaborators of Annabel Tuckfield. A scholar is included among the top collaborators of Annabel Tuckfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annabel Tuckfield. Annabel Tuckfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Tacey, Mark, Shaun Fleming, Andrew H. Wei, et al.. (2018). Prognostic markers in core‐binding factor AML and improved survival with multiple consolidation cycles of intermediate‐/high‐dose cytarabine. European Journal Of Haematology. 101(2). 174–184. 7 indexed citations
2.
Wallace, Daniel F., et al.. (2017). The dynamics of hepcidin‐ferroportin internalization and consequences of a novel ferroportin disease mutation. American Journal of Hematology. 92(10). 1052–1061. 14 indexed citations
3.
Mallett, Andrew J., Peter Hughes, Jeff Szer, et al.. (2015). Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort. Internal Medicine Journal. 45(10). 1054–1065. 27 indexed citations
4.
Gilbertson, Michael, Annabel Tuckfield, & Surender Juneja. (2012). Myelodysplastic Syndrome with t(1;7) Associated with Marked Dysmegakarypoiesis & Severe Thrombocytopenia: A Case Report and Review of the Literature. SHILAP Revista de lepidopterología. 2012. 1–4. 1 indexed citations
5.
Tsang, David, Annabel Tuckfield, & Christopher MacIsaac. (2011). Audit of safety and quality of the use of enoxaparin for anticoagulation in continuous renal replacement therapy. Critical Care and Resuscitation. 13(1). 24–27. 5 indexed citations
6.
Tuckfield, Annabel, et al.. (2008). Abbreviated dose rituximab for immune‐mediated hematological disorders. American Journal of Hematology. 83(7). 554–557. 10 indexed citations
7.
Ng, Ashley P., et al.. (2008). Resolution of platelet function defects with imatinib therapy in a patient with chronic myeloid leukaemia in chronic phase. Blood Coagulation & Fibrinolysis. 20(1). 81–83. 9 indexed citations
8.
Hedley, A J, Shaun Flint, Annabel Tuckfield, Rowan G. Walker, & S. Cohney. (2008). Alloimmune haemolysis in a renal transplant recipient receiving sirolimus. Clinical Kidney Journal. 1(3). 164–166. 4 indexed citations
9.
Stevenson, William, R Hoyt, Michel Guipponi, et al.. (2006). Genetic heterogeneity of granulocytes for the JAK2 V617F mutation in essential thrombocythaemia: implications for mutation detection in peripheral blood. Pathology. 38(4). 336–342. 13 indexed citations
10.
Renwick, William, et al.. (2006). Recombinant Activated Factor VII: Treating Postoperative Hemorrhage in Cardiac Surgery. The Annals of Thoracic Surgery. 81(3). 875–879. 48 indexed citations
11.
Tuckfield, Annabel, et al.. (2002). Binding of the RING Polycomb Proteins to Specific Target Genes in Complex with the grainyhead -Like Family of Developmental Transcription Factors. Molecular and Cellular Biology. 22(6). 1936–1946. 30 indexed citations
12.
Wilanowski, Tomasz, Annabel Tuckfield, Loretta Cerruti, et al.. (2002). A highly conserved novel family of mammalian developmental transcription factors related to Drosophila grainyhead. Mechanisms of Development. 114(1-2). 37–50. 126 indexed citations
13.
Ramamurthy, Lakshman, Virginia Barbour, Annabel Tuckfield, et al.. (2001). Targeted Disruption of the CP2 Gene, a Member of the NTF Family of Transcription Factors. Journal of Biological Chemistry. 276(11). 7836–7842. 30 indexed citations
14.
Tuckfield, Annabel, et al.. (1997). A novel form of hereditary sideroblastic anaemia with macrocytosis. British Journal of Haematology. 97(2). 279–285. 6 indexed citations
15.
Tuckfield, Annabel, Michael Haeusler, Andrew Grigg, & J. Metz. (1997). Reduction of inappropriate use of blood products by prospective monitoring of transfusion request forms. The Medical Journal of Australia. 167(9). 473–476. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026